Physician profile
Darren Sidney
NPI 1073600540
$128,656.68
in general payments reported to CMS, 2019-2025
34 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $4,212 · 2021: $12K · 2022: $3,803 · 2023: $19K · 2024: $47K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Food and Beverage: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $6,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,750.00 |
| Food and Beverage | $20,951.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,750.00 |
| Travel and Lodging | $6,629.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $70,942.65 | 2019-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Aveir |
| Boston Scientific Corporation | $25,101.55 | 2019-2025 | General - Ep, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Janssen Pharmaceuticals, INC | $15,166.78 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $7,495.89 | 2019-2025 | Carto 3, Thermocool Sf |
| Medtronic, INC. | $2,953.16 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Cardioinsight |
| E.R. Squibb & Sons, L.L.C. | $1,228.53 | 2019-2025 | Eliquis, Camzyos |
| Cardiva Medical, INC. | $912.36 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medtronic Vascular, INC. | $905.40 | 2019-2020 | |
| Atricure, INC. | $806.44 | 2019-2023 | |
| Pfizer INC. | $729.88 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $527.36 | 2019-2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $281.50 | 2019-2024 | |
| Volta Medical INC | $226.66 | 2023 | Vx1 |
| Philips North America LLC | $188.59 | 2022-2023 | |
| Cvrx, INC. | $184.60 | 2021-2024 | Barostim Neo System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acutus Medical, INC. | $171.32 | 2020 | |
| Preventice Services, LLC | $144.98 | 2019-2021 | |
| Biotronik INC. | $124.99 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor |
| Alnylam Pharmaceuticals INC. | $99.61 | 2023-2025 | Onpattro |
| Lundbeck LLC | $77.39 | 2019-2020 | |
| Altathera Pharmaceuticals LLC | $64.31 | 2021-2022 | |
| Heartflow, INC. | $48.02 | 2019 | |
| Impulse Dynamics (USA) INC. | $39.97 | 2022 | |
| Baxter Healthcare | $30.48 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Portola Pharmaceuticals, LLC | $30.28 | 2019 | |
| Irhythm Technologies, INC. | $27.94 | 2023 | Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $22.53 | 2024 | Arcalyst |
| Amgen INC. | $22.39 | 2019 | |
| Edwards Lifesciences Corporation | $21.66 | 2022 | |
| Angiodynamics, INC. | $20.41 | 2019 | |
| Cardiofocus, INC. | $16.92 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Sidney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.